Akesis Pharmaceuticals Files Pre-IND for AKP-020 (FinanzNachrichten)
Akesis Pharmaceuticals, ( Nachrichten ) Inc. (OTCBB:AKES) , an emerging diabetes drug-development company, today announced the filing of a preliminary Investigational New Drug (pre-IND) application with the U.S. Food and Drug Administration (FDA) for its lead product candidate AKP-020.

Vasogen Announces Second Quarter 2007 Results (FinanzNachrichten)
MISSISSAUGA, ON, July 10 /PRNewswire-FirstCall/ -- Vasogen Inc. ( Nachrichten ) (NASDAQ:VSGN; TSX:VAS), today reported the results of operations for the second quarter of 2007. All dollar amounts referenced herein are in Canadian dollars unless otherwise noted.